South Africa is targeting to inoculate five million senior citizens by the end of June, provided there is enough supply of vaccines.
Johannesburg, South Africa (17 May 2021) – Health Minister, Dr Zweli Mkhize, has confirmed that 87 sites are ready to open their doors to vaccinate the elderly as the country ramps up its biggest inoculation effort on Monday as the vaccine rollout gets underway.
Addressing the media on Sunday evening, Mkhize announced that South Africa was expecting an additional 325 260 doses of Pfizer vaccines, which arrived at midnight. This means the country now has 975 780 of the double dose jab as of 17 March 2021.
According to Mkhize, the government will run 83 of the vaccination sites, while four will be in the private sector.
“We need the private sector, and they are part of the system.”
He said his department was hoping to scale up these centres to about 200 by the end of the week.
The Minister reiterated the government’s strategy to immunise citizens who are aged 60 and above in the second phase of the COVID-19 vaccination plan as they are deemed the most vulnerable for becoming ill or dying of COVID-19.
“We will continue to vaccinate healthcare workers and complete the targeted 1.2 million by the end of the week,” the Minister added.
Meanwhile, he told journalists that the government was targeting to inoculate five million senior citizens by the end of June, provided there is enough supply of vaccines.
“As we speak, SMS messages are being dispatched with invitations to vaccinate tomorrow [on Monday], and over 7 000 are being dispatched to healthcare workers and 4 288 to citizens 60 years and above.”
He reminded citizens that vaccines should take their acceptable documents for identity verification such as ID card or book, drivers licence or passport. Meanwhile, people who belong to a medical aid scheme should carry their medical aid card or other details.
More vaccines expected
According to Mkhize, the country is expecting to receive 4.5 million doses of Pfizer and another two million from Johnson & Johnson (J&J).
“The J&J vaccine is still awaiting release from the Food and Drug Administration of America, and the J&J global head office is constantly updating us on progress in this regard. We hope to get finality this week,” he explained.
Sisonke Study
Mkhize said 478 733 South Africans had been vaccinated under the Sisonke Study that ended this weekend.
Sisonke is a collaboration between various stakeholders, including the National Department of Health, which allowed the government to make the COVID-19 J&J vaccine immediately available to healthcare workers using a research programme.
The programme received 500 000 doses.
However, he said the leftover doses would not be used in the second and third phases, but the South African Medical Research Council will conduct studies that will help delve into how vaccines work for people living with HIV and other comorbidities, elite athletes, pregnant and lactating women and other special groups.
“We know that everyone has been very anxious to know what will happen tomorrow [on Monday] and how we will start to vaccinate our most vulnerable citizens and then move onto vaccinating the general population,” he said.
by 